DUNN JEFFREY W sold $369K of SIBN
DUNN JEFFREY W sold 20,000 shares of SI-BONE, Inc. (SIBN) at $18.47 ($0.37M total) on 2026-10-01 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The filing provides fresh, primary‑source data but the transaction size is modest, limiting market impact.
Market read
Insider sales are monitored by traders; this modest director sale may cause slight short‑term pressure on SIBN.
What to watch
The 10b5-1 plan indicates pre‑planned execution, reducing the informational value of the sale.
Background
SEC Form 4 filing discloses a director's sale of SIBN shares under a pre‑arranged trading plan.
Ticker impact
Director Jeff Dunn sold 20,000 shares for $369,400 via a 10b5-1 plan, reducing his stake to 16,057 shares.
likely slight downward pressure as the market prices the insider sell
A director sold a sizable block under a pre‑arranged plan; such sales often prompt short‑term selling pressure.
Market effects
Minimal impact on the orthopedics device sector.
No broader regional effect.
Limited to investors tracking insider activity.
Counterpoint
The sale could be routine and unrelated to fundamentals, so price impact may be negligible.
Key entities
- companySI‑BONE, Inc.
Medical device maker specializing in spinal implants.
- personJeff Dunn
Director of SI‑BONE, executing a 10b5‑1 sale.
